Oregon Statutes 413.115 – Opioid Reversal Medication and Harm Reduction Clearinghouse Bulk Purchasing Fund
(1) The Opioid Reversal Medication and Harm Reduction Clearinghouse Bulk Purchasing Fund is established in the State Treasury, separate and distinct from the General Fund. Interest earned by the Opioid Reversal Medication and Harm Reduction Clearinghouse Bulk Purchasing Fund shall be credited to the fund.
Terms Used In Oregon Statutes 413.115
- Litigation: A case, controversy, or lawsuit. Participants (plaintiffs and defendants) in lawsuits are called litigants.
- State Treasury: includes those financial assets the lawful custody of which are vested in the State Treasurer and the office of the State Treasurer relating to the custody of those financial assets. See Oregon Statutes 174.100
(2) The Opioid Reversal Medication and Harm Reduction Clearinghouse Bulk Purchasing Fund consists of:
(a) Moneys received by the Oregon Health Authority from opioid litigation settlements;
(b) Grants awarded for the purpose of addressing substance use and overdose epidemics;
(c) Other gifts, grants, bequests, endowments or donations made to the fund; and
(d) Moneys appropriated to the fund by the Legislative Assembly.
(3) The moneys in the Opioid Reversal Medication and Harm Reduction Clearinghouse Bulk Purchasing Fund are continuously appropriated to the Oregon Health Authority for expenses related to opioid harm reduction. [2023 c.602 § 48]
413.115 was enacted into law by the Legislative Assembly but was not added to or made a part of ORS Chapter 413 or any series therein by legislative action. See Preface to Oregon Revised Statutes for further explanation.
[Amended by 1955 c.381 § 2; 1961 c.620 § 15; 1965 c.43 § 1; 1973 c.651 § 9; 2005 c.22 § 283; repealed by 2005 c.381 § 30]